Medtronic Launches Adaptive Brain Stimulation for Parkinson’s Disease Following EU Approval
EU Approval:
Medtronic has received CE Mark approval in the European Union and the United Kingdom for BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI), marking a significant advancement in personalized DBS therapy for Parkinson's disease patients12.
Innovative Technology:
BrainSense aDBS is the world's only closed-loop DBS system that provides real-time, self-adjusting brain stimulation based on each patient's unique brain activity, both in clinical settings and daily life12.
First Programming:
The first programming was completed by Dr. Martijn Beudel at Amsterdam University Medical Center, demonstrating the technology's potential to deliver patient-specific stimulation tailored to individual needs12.
Market Impact:
This approval strengthens Medtronic's market position in the European neuromodulation sector, with a substantial addressable market of 1.2 million Parkinson's patients in Europe and 10 million worldwide2.
Clinical Trials:
The Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) trial further highlights the potential of aDBS in clinical practice, evaluating the safety and effectiveness of chronic dual- and single-threshold aDBS modes compared to continuous DBS (cDBS)134.
Availability:
The technology will be available in Europe in early 2025, with FDA approval pending in the United States2.
Sources:
1. https://news.medtronic.com/2025-01-13-Medtronic-achieves-CE-Mark-approval-for-BrainSense-TM-Adaptive-deep-brain-stimulation-and-Electrode-Identifier,-a-groundbreaking-advance-in-personalized,-sensing-enabled-care-for-people-with-Parkinsons-through-innovative-brain-computer-interfac
2. https://www.stocktitan.net/news/MDT/medtronic-achieves-ce-mark-approval-for-brain-sense-tm-adaptive-deep-kgk8jaqc9ztb.html
3. https://news.medtronic.com/Medtronic-to-showcase-real-world-application-of-exclusive-BrainSense-TM-technology-and-groundbreaking-DBS-research-at-the-2024-International-Congress-of-Parkinsons-Disease-and-Movement-Disorders-R
4. https://www.clinicaltrialsarena.com/news/medtronic-teases-positive-data-adaptive-deep-brain-stimulation-trial/